
astellas pharma inc
Japan Approves World’s First Transdermal Beta-Blocker Patch
Toa Eiyo Ltd. has received manufacturing and marketing authorization in Japan for its transdermal Bisono® beta-blocker tape.
Amgen & Astellas Enter Into Japan Alliance
Amgen and Astellas Pharma Inc. today announced a strategic alliance to co-develop and co-commercialize new medicines in Japan.
Astellas, Ambryx Sign US$300 Million Antibody Drug Conjugate Deal
Astellas Pharma Inc. on Thursday entered into a collaboration with Ambrx Inc. for the discovery and development of novel antibody drug conjugates.
Astellas Pharma Releases Phase II Data For Leukemia Drug
Approximately 50 percent of FLT3-ITD positive AML patients achieved complete remission with Astellas Pharma's new investigational drug, according to Phase II data results.